Concepedia

Ze‐Hong Miao

ZM

Statistics

Publications

120

Citations

4.9K

H-Index

42

Active since

2001

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Shanghai Institutes for Biological Sciences

National Cancer Institute

Ze‐Hong Miao is an author at Shanghai Institute of Materia Medica specializing in pharmacology, cancer pharmacology, and oncology.

Publications per year

2001–2024

120

Publications

120

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Yiyue Ge, Tingzhong Tian, Suling Huang et al. · Signal Transduction and Targeted Therapy · 2021 · 204 citations · Full text

Pharmacy, Bioinformatics, Pharmacology +17

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Yiyue Ge, Tingzhong Tian, Suling Huang et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 168 citations · Full text

Medicine, Bioinformatics, Pharmacology +17

Novel Indenoisoquinolines NSC 725776 and NSC 724998 Produce Persistent Topoisomerase I Cleavage Complexes and Overcome Multidrug Resistance

Smitha Antony, Keli Agama, Ze‐Hong Miao et al. · Cancer Research · 2007 · 127 citations · Full text

Medicine, Oncology, Pharmacology +14

Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain

Lele Zhao, Danyan Cao, Tiantian Chen et al. · Journal of Medicinal Chemistry · 2013 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II

Stefano Giustino Manzo, Zhaoli Zhou, Ying-Qing Wang et al. · Cancer Research · 2012 · 111 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 120